Analyst- Investor Relation

Jubilant Bhartia Group

Jubilant Bhartia Group is a global conglomerate founded by Mr. Shyam S Bhartia and Mr. Hari S Bhartia with strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. Jubilant Bhartia Group has four flagships Companies- Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. Currently the group has a global workforce of around 43,000 employees.

Jubilant Pharmova Limited

Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses.

In the Radiopharma business, the Company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. Jubilant through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules.

The CRDMO business of the Company includes the Drug Discovery Services business that provides contract research and development services through two world-class research centres in Bangalore and Noida in India and the CDMO-API business that is involved in the manufacturing of Active Pharmaceutical Ingredients. Jubilant Therapeutics is involved in Proprietary Novel Drugs business and is an innovative biopharmaceutical company developing breakthrough therapies in the area of oncology and autoimmune disorders. The company operates six manufacturing facilities that cater to all the regulated market including USA, Europe and other geographies.

The Position

Organization- Jubilant Pharmova Limited

Designation - Analyst – Investor Relation

Location- Noida

Job Summary: Role will support the Investor Relations team in managing communications between the company and its investors. This role involves analysing financial data, preparing reports, and assisting in the development of investor presentations .

Key Responsibilities.

• Conduct financial analysis and modelling to support investor relations activities.
• Monitor and analyse competitor investor relations activities, market dynamics, and trends to inform strategic planning and positioning.
• Assist in the preparation of quarterly and annual reports, investor presentations, and other communication materials
• Maintain and update investor databases and contact lists.
• Manage investor inquiries and provide accurate and timely information.
• Collaborate with internal teams, including finance, legal, and communications, to ensure consistent messaging and compliance with regulatory requirements.

Qualification - MBA/ CPA, CFA, or CMA.

Experience – 4-6 Years of experience in investor relations, financial analysis,

Must Have -

• Strong understanding of financial statements and market data.
• Proficiency in financial analysis and modelling.
• Excellent communication and presentation skills.
• Ability to prepare detailed reports and investor materials.
• Proficiency in MS Office applications, including Excel, PowerPoint, and Word.
• Experience with investor relations software and databases.
• Knowledge of industry-specific regulations and compliance requirements .